Drug Shortage Report for KEVZARA

Last updated on 2020-03-06 History
Report ID 106826
Drug Identification Number 02472988
Brand name KEVZARA
Common or Proper name KEVZARA PEN 200MG/1.14ML
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) SARILUMAB
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2 pre-filled pens
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-03-03
Actual start date
Estimated end date 2020-03-13
Actual end date 2020-03-05
Shortage status Resolved
Updated date 2020-03-06
Company comments Production Delay: The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-03-06 English Compare
v5 2020-03-05 French Compare
v4 2020-03-05 English Compare
v3 2020-03-04 English Compare
v2 2020-02-21 French Compare
v1 2020-02-21 English Compare